Represents potential penetration into ~ 20% of the U.S. institutional market, while broadening access across long-term care and outpatient facilities U.S. losartan market totals $256M annually with ...

Scienture Holdings, Inc. (NASDAQ:SCNX) announced on Wednesday the formalization of multiple commercial group purchasing ...

Scienture Holdings, Inc. announced GPO agreements for its new drug, Arbli, providing access to over 2,500 healthcare ...

Regularly monitoring blood pressure is key to good health. But “garbage in = garbage out” as-always applies when it comes to ...

Another batch of medicines will be distributed across Mandaue City’s 27 barangays today, September 29, according to the City Health Office.

Multiple human rights and UN officials have raised grave concerns over violations of international law in the Gaza Strip (or Gaza) that have amounted to extermination and genocide.1–3 The Israeli ...

Your high blood pressure medication can have an effect on cholesterol levels, too. Learn which medications have an impact.

Actuate Therapeutics (ACTU) announced a corporate update on the regulatory path for elraglusib in pancreatic cancer and anticipated milestones ...

Arbli™ is the first and only ready-to-use liquid formulation of losartan, eliminating the need for compounding while offering reduced dosing volume and extended room-temperature shelf life COMMACK, NY ...

Scienture Holdings, Inc. (NASDAQ:SCNX) on Tuesday announced that it has formalized a commercial Pharmacy Benefit Manager (PBM) led Group Purchasing Organization (GPO) rebate agreement, advancing the ...

Neuland Laboratories Ltd. reported exports worth $12 million in August 2025, marking a massive 433% year-on-year growth and a 250% month-on-month surge.

Arbli is supplied as an peppermint-flavored oral suspension containing 10mg/mL of losartan potassium in 165mL bottles. The Food and Drug Administration (FDA) has approved Arbli ™, an oral suspension ...